What Is a Clinical Trial Readout? Why It Shapes Biotech Sentiment
A clinical trial readout is the public release of data from a clinical study. In biotech, the phrase usually refers to the first meaningful disclosure of results from a Phase 1, Phase 2, or Phase 3 trial. That readout may come as a company press release, a conference presentation, an abstract, an SEC filing, or a combination of sources. Regardless of format, the readout is one of the most important events in biotech because it converts scientific work into public evidence.